167 related articles for article (PubMed ID: 3060825)
1. Demonstration of opsonic and protective activity of human cord sera against type III group B streptococcus that are independent of type-specific antibody.
Kim KS; Wass CA; Hong JK; Concepcion NF; Anthony BF
Pediatr Res; 1988 Nov; 24(5):628-32. PubMed ID: 3060825
[TBL] [Abstract][Full Text] [Related]
2. Opsonic activity of human IgG and IgM antibody for type III group B streptococci.
Anthony BF; Concepcion NF
Pediatr Res; 1989 Oct; 26(4):383-7. PubMed ID: 2677951
[TBL] [Abstract][Full Text] [Related]
3. Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models.
Givner LB
Pediatrics; 1990 Dec; 86(6):955-62. PubMed ID: 2123536
[TBL] [Abstract][Full Text] [Related]
4. An IgA monoclonal antibody directed against type III antigen on group B streptococci acts as an opsonin.
Bohnsack JF; Hawley MM; Pritchard DG; Egan ML; Shigeoka AO; Yang KD; Hill HR
J Immunol; 1989 Nov; 143(10):3338-42. PubMed ID: 2681414
[TBL] [Abstract][Full Text] [Related]
5. Impaired chemotaxigenesis by type III group B streptococci in neonatal sera: relationship to diminished concentration of specific anticapsular antibody and abnormalities of serum complement.
Anderson DC; Hughes BJ; Edwards MS; Buffone GJ; Baker CJ
Pediatr Res; 1983 Jun; 17(6):496-502. PubMed ID: 6348689
[TBL] [Abstract][Full Text] [Related]
6. Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk.
Lagergård T; Thiringer K; Wassén L; Schneerson R; Trollfors B
Eur J Pediatr; 1992 Feb; 151(2):98-102. PubMed ID: 1537371
[TBL] [Abstract][Full Text] [Related]
7. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen.
Lin FY; Weisman LE; Azimi PH; Philips JB; Clark P; Regan J; Rhoads GG; Frasch CE; Gray BM; Troendle J; Brenner RA; Moyer P; Clemens JD
J Infect Dis; 2004 Sep; 190(5):928-34. PubMed ID: 15295698
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the opsonic and complement triggering activity of human monoclonal IgG1 and IgM antibody against group B streptococci.
Shyur SD; Raff HV; Bohnsack JF; Kelsey DK; Hill HR
J Immunol; 1992 Mar; 148(6):1879-84. PubMed ID: 1541826
[TBL] [Abstract][Full Text] [Related]
9. Transplacental or enteral transfer of maternal immunization-induced antibody protects suckling rats from type III group B streptococcal infection.
Heiman HS; Weisman LE
Pediatr Res; 1989 Dec; 26(6):629-32. PubMed ID: 2689988
[TBL] [Abstract][Full Text] [Related]
10. Opsonic and protective activity of immunoglobulin, modified immunoglobulin, and serum against neonatal Escherichia coli K1 infection.
Bortolussi R; Fischer GW
Pediatr Res; 1986 Feb; 20(2):175-8. PubMed ID: 3511443
[TBL] [Abstract][Full Text] [Related]
11. Variations in the opsonic requirements of group B streptococcus type III.
Hastings MJ; Easmon CS
Br J Exp Pathol; 1981 Oct; 62(5):519-25. PubMed ID: 7028075
[TBL] [Abstract][Full Text] [Related]
12. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus.
Butko P; Nicholson-Weller A; Wessels MR
J Immunol; 1999 Sep; 163(5):2761-8. PubMed ID: 10453019
[TBL] [Abstract][Full Text] [Related]
13. Functional activity of class-specific antibodies to type III, group B streptococcus.
Campbell JR; Baker CJ; Metzger TG; Edwards MS
Pediatr Res; 1988 Jan; 23(1):31-4. PubMed ID: 3277150
[TBL] [Abstract][Full Text] [Related]
14. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus.
Baker CJ; Rench MA; Edwards MS; Carpenter RJ; Hays BM; Kasper DL
N Engl J Med; 1988 Nov; 319(18):1180-5. PubMed ID: 3050524
[TBL] [Abstract][Full Text] [Related]
15. L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci.
Fujieda M; Aoyagi Y; Matsubara K; Takeuchi Y; Fujimaki W; Matsushita M; Bohnsack JF; Takahashi S
Infect Immun; 2012 Jun; 80(6):2053-60. PubMed ID: 22451515
[TBL] [Abstract][Full Text] [Related]
16. Type III group B streptococcal strain differences in susceptibility to opsonization with human serum.
Fischer GW; Hunter KW; Wilson SR
Pediatr Res; 1981 Dec; 15(12):1525-9. PubMed ID: 7033908
[TBL] [Abstract][Full Text] [Related]
17. Development of IgM antibody to group B Streptococcus type III in human infants.
Boyer KM; Klegerman ME; Gotoff SP
J Infect Dis; 1992 Jun; 165(6):1049-55. PubMed ID: 1583322
[TBL] [Abstract][Full Text] [Related]
18. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection.
Baker CJ; Edwards MS; Kasper DL
Pediatrics; 1981 Oct; 68(4):544-9. PubMed ID: 7033911
[TBL] [Abstract][Full Text] [Related]
19. [Antibodies to group B streptococci in maternal and cord sera].
Kubota T; Takada M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jun; 41(6):676-82. PubMed ID: 2527933
[TBL] [Abstract][Full Text] [Related]
20. A polyclonal human IgG preparation hyperimmune for type III, group B Streptococcus: in vitro opsonophagocytic activity and efficacy in experimental models.
Givner LB; Edwards MS; Baker CJ
J Infect Dis; 1988 Oct; 158(4):724-30. PubMed ID: 3049837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
